Riley Mccormack Insider Profile

4 Followers
Riley Mccormack, Ten Percent Owner at Arca Biopharma, holds 3.79M shares in Digimarc (Ticker: DMRC), holds 2.10M shares in Arca Biopharma (Ticker: ABIO).
tipranks
Riley Mccormack

Riley Mccormack
Arca Biopharma (ABIO)
Ten Percent Owner

Ranked #60,993 out of 98,384 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-6.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$112M
92.68%
7.32%
A breakdown of Riley Mccormack's holdings

Insider Roles

Digimarc
(DMRC)
CEO, Director, Ten Percent Owner
Arca Biopharma
(ABIO)
Ten Percent Owner
Roles that Riley Mccormack holds in companies

Most Profitable Insider Trade

Stock:
Arca Biopharma
(ABIO)
Rating:Informative Sell
Date:Jan 16, 2015 - Jan 16, 2016
Return:+34.00%
The most profitable trade made by Riley Mccormack

Riley Mccormack's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arca Biopharma
Jan 16, 2015
Ten Percent Owner
Informative Sell
267.50K
$8.23M
Digimarc
Feb 17, 2023
CEO, Director, Ten Percent Owner
Uninformative Buy
29.28K
$104.21M
List of latest transactions for each holding click on a transaction to see Riley Mccormack's performance on stock

Riley Mccormack insider profile FAQ

What is the percentage of profitable transactions made by Riley Mccormack?
The percentage of profitable transactions made by Riley Mccormack is 40%.
    What is the average return per transaction made by Riley Mccormack?
    The average return per transaction made by Riley Mccormack is -6.90%.
      What stocks does Riley Mccormack hold?
      Riley Mccormack holds: ABIO, DMRC stocks.
        What was Riley Mccormack’s latest transaction?
        Riley Mccormack latest transaction was an Uninformative Buy of $29.28K.
          What was Riley Mccormack's most profitable transaction?
          Riley Mccormack’s most profitable transaction was an Informative Sell of ABIO stock on January 16, 2015. The return on the trade was 34.00%.
            What is Riley Mccormack's role in Arca Biopharma?
            Riley Mccormack's role in Arca Biopharma is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.